Ignite Creation Date:
2026-03-26 @ 3:15 PM
Ignite Modification Date:
2026-03-31 @ 6:50 AM
Study NCT ID:
NCT07474792
Status:
NOT_YET_RECRUITING
Last Update Posted:
2026-03-16
First Post:
2026-03-11
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Dose Ranging Study of ORKA-002 in Patients With Moderate-to-Severe Plaque Psoriasis
Sponsor:
Oruka Therapeutics, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2026-03
Start Date Type:
ESTIMATED
Primary Completion Date:
2027-10
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-04
Completion Date Type:
ESTIMATED
First Submit Date:
2026-03-11
First Submit QC Date:
None
Study First Post Date:
2026-03-16
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2026-03-11
Last Update Post Date:
2026-03-16
Last Update Post Date Type:
ACTUAL